1. Germany Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
M1 Kliniken AG

M1 Kliniken AG

M12.DE
M1 Kliniken AGDE flagDeutsche Börse
18.86
EUR
-0.42
- -
354.16MMarket Cap
M1 Kliniken AG
M12.DE
(Deutsche Börse)

Recent

price

18.86

P/E

ratio

- -

div

yld

- -

ROIC.AI

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
1.53
2.33
2.4
3.07
3.88
4.41
8.59
16.02
14.52
16.1
17.27
18.55
Revenue per Share
0.31
0.44
0.33
0.38
0.39
0.56
0.37
0.45
0.22
0.52
0.82
1.13
Basic EPS, GAAP
- -
- -
0.46
-0.09
0.03
-0.38
0.44
0.73
0.97
0.35
1.48
1.93
Free Cash Flow per Basic Share
- -
- -
0.3
0.29
0.29
0.3
0.01
0.08
0.09
0.1
0.47
0.47
Dividend per Share
1.67
1.94
1.97
2.15
2.12
2.3
2.56
2.9
3.03
3.55
3.92
4.56
Book Value per Share
0.76
1.45
1.47
2.54
3.3
3.42
4.14
4.05
4.21
2.84
2.38
3.05
Tangible Book Value per Share
15
15
15
15
17
18
19
20
20
20
20
20
Basic Weighted Avg Shares
23
35
36
47
65
77
160
315
285
316
339
364
Sales/Revenue/Turnover
6.29
18.81
12.14
12.09
9.81
10.12
5.94
3.86
3.14
4.63
7.7
10.09
Operating Margin (%)
- -
- -
- -
- -
1
3
4
6
6
5
5
5
Depreciation Expense
5
7
5
6
7
10
7
9
4
10
16
22
Net Income, GAAP
5.07
2.07
8.76
21.43
18.31
23.66
15.41
24.57
30.91
29.06
32.35
29.25
Effective Tax Rate (%)
19.92
18.99
13.93
12.24
10.14
12.6
4.28
2.83
1.51
3.25
4.72
6.08
Profit Margin (%)
-3
16
15
26
39
45
64
67
70
52
40
58
Working Capital
1
- -
- -
- -
- -
9
9
8
10
8
7
5
LT Debt
25
30
30
47
64
68
115
140
143
143
134
150
Total Equity
- -
22.42
13.14
11.35
9.19
8.18
7.68
6.49
3.95
6.51
11.34
16.58
Return on Invested Capital (%)
- -
24.53
17.1
18.41
19.2
22.92
9.71
7.51
1.82
8.51
13.76
17.55
Return on Capital (%)
- -
24.48
17.07
18.46
19.24
25.64
15.54
17.01
7.41
15.89
21.84
26.59
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
19.8%
5.83%
11.77%
Free Cash Flow
797.99%
80.5%
30.43%
Net Income, GAAP
23.37%
42.21%
38.17%
Sales/Revenue/Turnover
31.08%
22.67%
7.4%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
316
2024
- -
- -
- -
- -
339
2025
- -
- -
- -
- -
364

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.52
2024
- -
- -
- -
- -
0.82
2025
- -
- -
- -
- -
1.13

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.1
2024
- -
- -
- -
- -
0.47
2025
- -
- -
- -
- -
0.47
Similar Companies
American Mobile Dental Corp. (AMBD)
Vaidya Sane Ayurved Laboratories Ltd. (MADHAVBAUG.NS)
Cano Health, Inc. (CANO)
Shalby Limited (SHALBY.BO)
RHON-KLINIKUM AG Unsponsored ADR (RKAGY)
Esperite N.V. (ESP.AS)
Business
M1 Kliniken AG, a Germany-based operator of healthcare facilities focused on aesthetic medicine and plastic surgery, provides a range of beauty medical treatments and services through its Beauty segment, including breast augmentation, eyelid lifts, liposuction, abdominoplasty, nose corrections, face lifts, upper arm and thigh lifts, labia corrections, wrinkle treatments, lip treatments, and injections with hyaluronic acid and botulinum toxin; it also operates specialist centers under the M1 Med Beauty brand at more than 35 locations across Germany, as well as the M1 Schlossklinik in Berlin, one of Europe's largest facilities for plastic and aesthetic surgery with six operating theaters and 35 beds. Through its Trade segment, the company sells pharmaceuticals and medical products for therapeutic areas such as oncology, HIV/AIDS, neurology, rheumatology, chronic diseases, and aesthetic medicine. M1 Kliniken AG markets high-quality products under the M1 Select and M1 Aesthetics brands to private customers, doctors, pharmacies, and wholesalers; it conducts operations in Germany, Austria, Switzerland, the Netherlands, the United Kingdom, and Australia, targeting price-sensitive consumers seeking high-quality aesthetic procedures. Founded in 2007 and headquartered at Gruenauer Strasse 5 in Berlin, Germany, the company functions as a subsidiary of MPH Health Care AG and employs over 350 staff, performing more than 400,000 minimally invasive and surgical procedures annually with specialized doctors trained at the M1 Akademie. In recent developments, M1 Kliniken AG formerly known as M1 Beauty AG reports strong financial performance in the first half of 2025 with group revenue up 9.4% to EUR 183.5 million, EBIT growth of 24% driven by efficiency measures and capacity expansions in the Beauty segment, alongside a sustained share buyback program initiated in April 2024 extending through April 2025 involving up to 1 million shares; the company pursues ongoing clinic network expansion and international growth while exploring strategic options for its Trade segment, including early-stage investor interest.